1st Quarter - Report

EPILEPSY FOUNDATION for EPILEPSY FOUNDATION

Firm
Client
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

Support for United Nations disability rights treaty (CRPD)

LobbyistCovered position, as disclosed
ANGELA OSTROM —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; White House Office

Health Issues HCR

Health care reform legislation; Medicare and Medicaid related issues and prescription drug policy; Medicare policy reforms Prescription drug access issues; support for epilepsy awareness programs

LobbyistCovered position, as disclosed
ANGELA OSTROM —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); White House Office; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Labor, HHS, Education and Related Agencies appropriations for NIH, CDC, HRSA Funding for Lifespan Respite Care Act Funding for epilepsy research and programs Prescription drug access issue appropriations

LobbyistCovered position, as disclosed
ANGELA OSTROM —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.